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Graphical Abstract 
 
Highlights 
 Determination of the proton dissociation constants of arylphosphonic acid derivatives 
 Comparison of our experimental values to predicted and formerly measured pKa values   
 Hammett equations of proton dissociation of arylphosphonic acid derivatives were refined 
Abstract 
Determination of the proton dissociation constants of several arylphosphonic acid derivatives was 
carried out to investigate the accuracy of the Hammett equations available for this family of 
compounds. For the measurement of the pKa values modern, accurate methods, such as the 
differential potentiometric titration and NMR-pH titration were used. We found our results 
significantly different from the pKa values reported before (pKa1: MAE= 0.16 pKa2: MAE=0.59). Based 
on our recently measured pKa values, refined Hammett equations were determined that might be 
used for predicting highly accurate ionization constants of newly synthesized compounds (pKa1 = 1.70 
– 0.894σ, pKa2 = 6.92 – 0.934σ). 
Keywords: Arylphosphonic acids; ; ; ; , Hammett equation, pH-metric pKa measurements, NMR-pH 
titration, pKa predictors  
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1 Introduction 
Arylphosphonates are widespread intermediates in the synthesis of arylphosphonic acids [1] and 
many of these compounds possess biological activity. In recent years, several potential 
pharmaceutical applications of biologically active molecules containing arylphosphonic acid unit and 
its derivatives have been reported, like metabotropic glutamate receptor antagonists [2–5], tyrosine 
kinase inhibitors [6], protein tyrosine phosphatase inhibitors [7], carbonic anhydrase inhibitors [8], 
growth factor receptor bound protein 2 SH2 domain inhibitors [9], metallo-ß-lactamase inhibitors 
[10] and eIF4E inhibitors [11].(Fig. 1.) 
Proton-dissociation capability has a great impact on both pharmacodynamics and pharmacokinetic 
properties of drug molecules. The majority of contemporary therapeutic substances possess 
acid/base character according to a 2013 chemogenomic analysis [12]. Quantitative description of 
ionization state, as described by proton dissociation constant (pKa), has therefore a crucial role in 
drug discovery. Moreover, pKa value also reflects the ionization state of active pharmaceutical 
ingredients in various physiologically relevant media. Ionization has a characteristic impact on 
ADMET (A: absorption, D: distribution, M: metabolism, E: excretion, T: toxicity) properties, including 
solubility, lipophilicity, dissolution rate, membrane permeability, plasma protein binding, CNS 
penetration, P-gp efflux, hERG inhibition and cytochrome P450 inhibition [13]. The calculation of 
distribution coefficient (logD) also requires accurate pKa values. Since ionization is a crucial factor 
among the drug-like properties, the measurement of the pKa value(s) of new chemical substances is 
required by both the FDA (Food and Drug Administration) and the OECD (Organizations for Economic 
Cooperation and Development). 
The pKa values can be determined by experimental methods or predicted by in silico calculations. 
There are a number of experimental techniques available for the evaluation of proton dissociation 
constant, such as potentiometric and spectrophotometric titrations, capillary electrophoresis (CE), 
HPLC and NMR-pH titration [14–16]. Among them the most extensively used is the pH-
potentiometric method, in the industrial drug discovery settings [15], due to the robust generally 
applicable methodology, which provides reliable pKa values even in medium throughput mode. 
Although experimental pKa values are essential for the characterization of drug discovery 
compounds, effective design of new drug-like molecules also requires efficient in silico tools for 
prediction of ionization constants. The in silico methods of pKa prediction can be classified into two 
major groups: empirical methods and methods based on quantum chemical calculations. The 
empirical methods can be further divided into three subgroups based on the approach they use: 
methods utilizing empirical relations of Hammett and Taft (Linear free-energy relationships (LFER) 
methods), methods correlating calculated structural descriptors with pKa (Quantitative structure–
property relationships (QSPR) methods) and database lookup methods that calculate the pKa based 
on experimental pKa values of structurally similar molecules of a predetermined database[17]. 
The classic empirical method used for predicting pKa values is based on the Hammett equation. In 
1935, Hammett found a linear relationship between the pKa values and the substitution parameters 
(Hammett σ) of the substituents in the case of benzoic acid and its meta- and para-substituted 
derivatives [18,19]. 
 log(Ka,S/Ka,0)=σS Eq. (1) 
A similar relationship was found in the case of aliphatic and ortho-substituted aromatic compounds 
by Taft et al. in 1952 [20–22]. Based on these observations the initial equation can be extended for 
multiple substituents and classes of compounds leading to the following general equation: 
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 pKa,S = pKa,0 - ρ∑σS Eq. (2) 
referring to compounds/reactions where the pKa proton dissociation constants are influenced by 
electronic substituent effects only, and steric effects do not occur. In Eq. (2) pKa,0 is the proton 
dissociation constant of the parent molecule of the class of compounds, pKa,S is the proton 
dissociation constant of the substituted derivative, σS is the electronic substituent constant, 
characteristic to a given substituent, ρ is the reaction constant, or sensitivity constant, which 
describes the susceptibility of the reaction to substituent effects, compared to the ionization of 
benzoic acid. Since the pKa values of phosphonic acid derivatives depend on the substituents of the 
aromatic ring, the use of a Hammett-type equation to predict the pKa values in this class of 
compounds is valid. 
There are several publications on determining the parameters of Hammett equations and Taft 
equations for arylphosphonic acids in the literature [23–25]. However, the experimental pKa values 
used for this purpose are highly variable due to varying experimental environment (ionic strength, 
temperature) and outdated measurement techniques. As a consequence, the Hammett equations of 
arylphosphonic acids reported before might describe the correlation between substituents and pKa 
values less accurately. Therefore, here we report the pKa values of several arylphosphonic acids 
measured by highly accurate methods (differential pH-metric titration, NMR-pH titration), compare 
the results with in silico predicted values (cpKa) and those measured by Nagarajan et al. [26] based on 
the goodness of the correlation (R2, s) and the mean absolute error (MAE) of the compared pKa 
values, and determine a more accurate Hammett equation for arylphosphonic acid derivatives. 
2 Materials and methods 
2.1 Materials 
The arylphosphonic acids were synthetized at the Department of Organic Chemistry and Technology 
at Budapest University of Technology and Economics and 4 further arylphosphonic acids were 
purchased from Sigma-Aldrich Co. LLC (St. Louis, MO, The United States). The titration reagents (0.5 
M potassium hydroxide, hydrochloride acid, and potassium chloride), phosphoric acid solution (85%), 
cc. acetic acid, tetramethylsilane (TMS) were purchased from Sigma-Aldrich Co. LLC (St. Louis, MO, 
The United States), methanol was purchased from Merck Millipore.  
2.2 pH-metric pKa measurements 
In the case of compounds 1a-g and 1o-s, the ionization constants of arylphosphonic acids were 
measured by pH-metric titration method as described earlier [27].  
In the case of compounds 1h-n and 1t-z, the SiriusT3™ automated pKa analyser (Sirius Analytical 
Instruments Ltd., Forest Row, UK) fitted with combination Ag/AgCl pH electrode was used for 
determination of dissociation constants. The pKa values were calculated by SiriusT3Refine™ software 
(Sirius Analytical Instruments Ltd., Forest Row, UK). Methodologies used by the software have been 
described in earlier publications [28,29]. 
In each experiment, 1.50 mL of a 1-5 mM aqueous solution of sample was titrated by the same 
method, under the same circumstances as in the case of the measurement with the GLpKa 
apparatus. Three parallel measurements were carried out and the pKa values of samples were 
calculated by SiriusT3Refine™ software. 
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In the case of compounds where we could not measure the proton dissociation constants in aqueous 
medium due to poor aqueous solubility, the cosolvent dissociation constants (psKa values) were 
determined in various MeOH–water mixtures (between 15:85 and 70:30, w/w). The same titration 
protocol was performed as above. Each sample was measured in minimum six different MeOH–water 
mixtures. To obtain the aqueous pKa value from psKa data Yasuda–Shedlovsky extrapolation method 
has been used. This method establishes a correlation with the dielectric constant (ε) using the 
following equation: 
 psKa + log[H2O] = a∙ε + b  Eq. (3) 
where log[H2O] is the molar water concentration of the given solvent mixture. This method is the 
most widely used procedure in cosolvent techniques[30,31]. 
2.3 NMR-pH pKa measurements 
The 31P, 13C, and 1H NMR spectra were obtained on a Bruker DRX-500 spectrometer 
operating at 202.4, 125.7, and 500 MHz, respectively. Chemical shifts are downfield relative to 
85% H3PO4 or TMS. The couplings are given in Hz. 
For the determination of the low pKa (< 2.5) values of the aromatic phosphonic acid 
derivatives 1H NMR-pH titrations were applied. Depending on the solubility, a 0.1–2 mM analyte 
solution was prepared containing 1 mM dichloroacetic acid as an NMR-pH indicator and 0.05 M 
2,2-dimethyl-2-silapentane-5-sulfonate as a chemical shift reference in a 5% D2O 95% H2O 
solution. The presence of such a minute amount of D2O in the sample, results in less than 0.02 
pH unit difference in the pH scale. The ionic strength of the solutions was set to 0.15 M with KCl. 
A minimum of 15 titration points (i.e. 15 various pH solutions) were prepared in the pH range of 
0.6–4.0.  
The NMR measurements were carried out on 600 MHz Varian DDR NMR spectrometer 
equipped with a 5 mm inverse-detection gradient (IDPFG) probehead at 25.0 ± 0.2 °C. 1H NMR 
spectra of the solutions were recorded with a double pulse field gradient spin echo pulse sequence 
to suppress the water signal and the spectra were processed by a VnmrJ 3.2 C/Chempack 5.1 
software. The low pKa values of phosphonic acids were determined by the Perrin–Fabian method 
without the direct measurement of the pH during the titrations [32]. Fitting the 1H chemical shifts 
of the analyte protons as a function of the 1H NMR chemical shift of the NMR-pH indicator 
dichloroacetic acid singlet, resulted in the pKa difference (ΔpK) between dichloroacetic acid and 
the analyte. 
 𝛿Lobs  =  𝛿L + 
(𝛿HL − 𝛿L)(𝛿Iobs − 𝛿I)
(1 − 10∆p𝐾)(𝛿Iobs − 𝛿I) + 10∆p𝐾(𝛿HI − 𝛿I)
  Eq. (4) 
where δLobs is the observed chemical shift of the analyte, δIobs is the measured chemical 
shift of the dichloroacetic acid, δHL and δL are the limiting chemical shifts of the protonated and 
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non-protonated species while δHI and δI stand for the limiting chemical shifts of the protonated 
and the anionic forms of dichloroacetic acid, respectively. 
The chemical shifts of the aromatic protons in a given compound were fitted 
simultaneously by the OriginPro 8 software. During the fitting, the limiting chemical shifts of 
dichloroacetic acid were kept constant at δHI = 6.341 and δI = 6.051. These limiting chemical 
shift values were determined by Szakacs et al. [33] at 0.15 M ionic strength. The low pKa values 
of the phosphonic acid derivatives were calculated from the ΔpK values and the pKa of 
dichloroacetic acid (pKa = 1.14). 
2.4 HRMS measurements 
HRMS analyses were performed on a LTQ FT Ultra (Thermo Fisher Scientific, Bremen, 
Germany) system. The ionization method was ESI and operated in positive ion mode. The 
protonated molecular ion peaks were fragmented by CID at a normalized collision energy of 45%. 
The samples were solved in methanol-water (1:1, v/v) acidified with 1 V/V% cc. AcOH. Data 
acquisition and analysis were accomplished with Xcalibur software version 2.0 (Thermo Fisher 
Scientific). 
3 Results and discussion 
To further investigate the substituent effects on the pKa values of arylphosphonic acids, beside the 
formerly synthesized molecules (1a-g and 1o-s), we synthesized 10 more arylphosphonic acid 
derivatives (1h-j and 1t-z) using the method published before [27], and carried out structural 
identification based on NMR and HRMS measurements (See the Supplementary material). We also 
purchased further 4 derivatives (1k-n) from Sigma Aldrich Co.. Altogether we carried out the pKa 
measurements of 26 compounds (Table 1.) using up-to-date methods and determined accurate pKa 
values of the proton dissociation equilibria of arylphosphonic acid derivatives (Fig. 2.). The pKa values 
of 5 compounds, 1t-x have not been reported before. 
pKa2 values of the second dissociation step of arylphosphonic acid derivatives and 
pKa,COOH values of carboxyl groups were measured by differential pH-metric titrations. In the case of 
pKa1 values (the first dissociation step of arylphosphonic acid) we used NMR-pH titration technique 
since most pKa values were outside of the operational pH range of the pH-metric method (pH 1.8-
12.0).[34] (Table A.1-A.2, see Appendices) 
The measured pKa values were compared with those reported by Nagarajan et al. [26] and also with 
calculated pKa values (cpKa) predicted by the Chemaxon/Marvin Sketch 16.10.17 plugin [35], as well 
as the ACD/Percepta pKa predictor module of Advanced Chemistry Development, Inc. (ACD/Labs) 
using the Classic and GALAS models [36]. (Table A.1-A.2, see Appendices) Finally, the new Hammett 
equations were determined based on the in-house results. 
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3.1 Comparison of the results measured by us with those of Nagarajan et al.  
We compared our experimental pKa values with those measured by Nagarajan et al. [26] using linear 
regression analysis and the mean absolute error (Table 2.). Altogether 16 compounds were involved 
in this comparison as shown by Table A.1-A.2. 
These data show that the correlation in the case of the first proton dissociation step (pKa1) is slightly 
better with an acceptable MAE, while in the case of the second proton dissociation step of 
arylphosphonic acids (pKa2) all three values indicate a worse correlation and a significant MAE, 
exceeding the margin of error (0.59 > 0.50 [37–39]). This might be caused by the following potential 
sources of measurement error Nagarajan’s experimental pKa values suffer from: 
a) they used a less accurate, now obsolete direct potentiometric method, 
b) most of the reported pKa values are out of the standardization range of the pH meter they 
used (pH 2.0 to 7.0), 
c) they corrected their values to zero ionic strength, while modern commercial potentiometric 
pKa analysers work based on the constant ionic medium reference state method, using a 
0.15 M KCl background electrolyte to improve the measurement’s precision and to mimic 
the physiological salt level [40]. 
3.2 Comparison of predicted and experimental pKa values 
As can be seen in Table 3. and Figure A.1. (see Appendices), a good correlation was found for the full 
in-house data set between measured and in silico predicted pKa values when using the ACD/Percepta 
pKa predictor with the Classic model (pKa1: R2=0.851; pKa2: R2=0.819), while poor correlations were 
found in case of the other two predictors. The better results of the former pKa predictor might be 
caused by the fact that it uses Hammett-type equations and electronic substituent constants (σ) 
when calculating the pKa values. The other two predictors using microconstants for predicting the pKa 
values seem to have problems with predicting accurate values for the set of compounds we studied. 
In the next step the predicted and experimental pKa values were compared for the overlapping 
points in Nagarajan’s data set and our data, i.e. altogether 16 compounds were involved in this 
comparison. In general, better correlations were found for pKa1 values and for Nagarajan’s data set, 
however, in two cases the MAE calculated for this data set exceeds the acceptable value (>0.50 [37–
39]) (Table 4., Fig. A.2., see Appendices). It is also notable, that in the case of the ACD/Percepta pKa 
predictor using the Classic model, the MAE values are significantly better for Nagarajan’s set, 
suggesting that the predictor’s database contains similar pKa values and Hammett equations to those 
reported by Nagarajan et al. The relatively high MAE of prediction in the case of the in-house pKa2 
values might also be a consequence that this predictor’s database contains inaccurate pKa values and 
Hammett equations. 
3.3 Hammett sensitivity constants 
To determine the sensitivity constant (ρ) for arylphosphonic acid derivatives Eq. 2. was rearranged to 
the following form:  
 pKa,0 - pKa,S= ρ∑σS Eq. (5.) 
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Then the sensitivity constant ρ can be determined by plotting the difference of pKa values of the 
parent compound (1a) and its meta and para substituted derivatives (1c-e, 1g-r, 1t-z) against the 
sum of Hammett σ values of the R2 to R4 substituents of (1), obtained from lookup tables in reference 
[41] and fitting a line onto the data points using linear regression analysis with no intercept 
(regression through the origin). The sensitivity constant is given by the slope of the regression line.  
The ortho substituted derivatives (1b, 1f, 1s) should be omitted from the calculation because in the 
case of ortho substituents steric effects also occur, and therefore Eq. (2) does not describe such 
compounds. 
There are further two derivatives that need special attention: they are compounds (1y) and (1z) 
containing a carboxyl group in the para and meta position of (1), respectively. Table A.2. shows that 
the differences pKa,COOH - pKa1 and pKa,COOH - pKa2 (where pKa, COOH describes the proton dissociation of 
the carboxyl group of compounds 1y and 1z) are in the range of 2.2 to 3 pKa units. This means that in 
the pH range used in the course of determining the experimental values of pKa1 and pKa2 both the 
unionized COOH and ionized COO− form of the carboxyl group of compounds (1y) and (1z) exist. Of 
course, it can be stated that in the pH range used when determining pKa1 the unionized COOH form 
will dominate, whereas in the pH range used when determining pKa2 the ionized COO− form will 
dominate. 
It follows that compounds (1y) and (1z) should be characterized by σp,COOH and 
σm,COOH, respectively, in the correlation of (pKa1,0 - pKa1,S) with ∑σS and by σp,COO- and σm,COO-, 
respectively, in the correlation of (pKa2,0 - pKa2,S) with ∑σS. 
The results of regression analyses performed for altogether 22 data points on the basis of Eq. (5) and 
the above considerations are shown in Table 5. It can be seen that much better correlation was 
found for pKa2 than pKa1 (R2=0.917 and 0.862, respectively). An analysis of the residuals (differences 
between experimental and predicted ΔpKa1 values) revealed that the worse correlation is due to 
compound (1z) being an outlier in the linear regression. This is probably caused by the fact that this 
compound was characterized with the substituent constant σm,COOH as if only the unionized form of its 
carboxyl group were present, although we know that the ionized carboxylate form also exists in the 
pH range used when determining the pKa1 value of this compound. This may be the case to a lesser 
extent with compound (1y) for pKa1 and with compounds (1y) and (1z) for pKa2. Therefore, the above 
regression analysis was performed again without compounds (1y) and (1z), i.e. for altogether 20 data 
points. The results are shown in Table 5 and Figure 3. These regression results are considered the 
final ones. 
Table 5 shows that the sensitivity constants (ρ) determined for pKa1 and pKa2 values are 0.894 and 
0.934, respectively. Using the new ρ values, the Hammett equations describing the first and second 
dissociation step of arylphosphonic acids are given in Table 5. 
Comparing the new equations with the formerly reported ones, we can observe that our ρ values are 
similar to those determined by Nagarajan’s group. However, there are significant differences in the 
parent compound’s pKa values (the intercept of the Hammett equation), which might cause 
substantial errors during pKa predictions, especially in the case of pKa2 values (Eq. 7. vs. Eq. 9.), where 
the difference exceeds 0.5 pKa units. It is even more unfortunate, because the knowledge of accurate 
pKa2 values is essential since they are in the physiologically significant pH range. The standard errors 
of measured pKa,0 values (SD < 0.005) have no considerable effect on the goodness of prediction of 
pKa1 and pKa2 values (Eq. 8-9.) compared to the standard errors of Hammett ρ parameters. 
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4 Conclusions 
In this study, we carried out a thorough analysis of pKa values of 26 different arylphosphonic acid 
derivatives of which 5 compounds’ pKa values were not reported before. Comparing our 
experimental pKa values to predicted ones we found a good correlation with predicted pKa values 
calculated by the Hammett-type equation based ACD/Percepta pKa predictor module using the 
Classic model, while the microconstant based predictors proved to be less accurate. Comparing our 
results to experimental values previously reported by Nagarajan et al. we found significant 
divergence, especially in case of pKa2. It might stem from the different accuracy of the methods used 
by Nagarajan (direct potentiometry, zero ionic strength) and the up-to-date methods used in this 
study (differential potentiometry, NMR-titration, constant ionic strength). Based on our results we 
refined the Hammett equation for arylphosphonic acids, the new parameters, together with our 
measured pKa values might be used for more accurate pKa prediction of arylphosphonic acid 
derivatives. The refinement of the key parameters of pKa prediction provides a reliable physico-
chemical characterization of novel drug-like molecules, and refreshes pKa databases, which can lead 
to more efficient early-stage drug discovery processes. 
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Figure 1. Examples of biologically active arylphosphonic acid derivatives 
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Figure 2. Proton dissociation steps of arylphosphonic acid derivatives (1) 
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Figure 3. Determination of Hammett sensitivity constants (n=20 data points, 1c-e, 1g-r, 1t-x) 
 
Table 1. Substituents of the investigated arylphosphonic acids (1a-z) 
1 R1 R2 R3 R4 
a H H H H 
b Me H H H 
c H H Me H 
d H H OCF3 H 
e H H OMe H 
f F H H H 
g H F H H 
h H OMe H H 
i H H Cl H 
j H Cl H H 
k H H Br H 
l H NO2 H H 
m H H Et H 
n H H EtO H 
o H H C(O)CH3 H 
p H H CF3 H 
q H H cyclohexyl H 
r H H F H 
s F H H F 
t H H Ph H 
u H Ph H H 
v H H nPr H 
w H C(O)CH3 H H 
x H H tBu H 
y H H COOH H 
z H COOH H H 
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Table 2. Results of comparison of in-house and formerly reported pKa values (n=16 compounds, 1a-
n, 1y-z, see Table A.1-A.2) 
Parameters* pKa1 pKa2 
R2 0.899 0.842 
s 0.087 0.123 
MAE 0.16 0.59 
*R2 and s are the squared correlation coefficient and the standard error of estimate, respectively, of the linear 
regression pKa, in-house = a * pKa, Nagarajan + b, and MAE is the mean absolute error calculated as follows: MAE= 
(1/n) * |pKa, in-house – pKa, Nagarajan|  
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Table 3. Comparison of predicted and measured pKa values for the full in-house set (n= 26 
compounds, 1a-z, see Table A.1-A.2) * 
In-house pKa1  ACD Classic  ACD GALAS  Marvin Sketch 
R2  0.851  0.746  0.603 
s  0.103  0.134  0.168 
MAE  0.16  0.21  0.24 
       
In-house pKa2  ACD Classic  ACD GALAS  Marvin Sketch 
R2  0.819  0.500#  0.573 
s  0.127  0.211  0.195 
MAE  0.46  0.22  0.20 
* R2 and s are the squared correlation coefficient and the standard error of estimate, respectively, of the linear 
regression pKa, experimental = a * pKa, predicted + b, and MAE is the mean absolute error calculated as follows: MAE= 
(1/n) * |pKa, experimental – pKa, predicted|.   
# The particularly low correlation is due to the outlying points belonging to compounds 1y-z, containing 
carboxyl functional group. By excluding them the correlation improves significantly (R2=0.756, n=24)  
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Table 4. Comparison of predicted and measured pKa values for the overlapping sets of 
experimental data (n=16 compounds, 1a-n, 1y-z, see Table A.1-A.2) * 
pKa1 
 ACD Classic  ACD GALAS  Marvin Sketch 
 In-house Nagarajan  In-house Nagarajan  In-house Nagarajan 
R2  0.768 0.885  0.752 0.831  0.658 0.803 
s  0.132 0.091  0.137 0.110  0.160 0.119 
MAE  0.17 0.04  0.23 0.12  0.17 0.21 
          
pKa2 
 ACD Classic  ACD GALAS  Marvin Sketch 
 In-house Nagarajan  In-house Nagarajan  In-house Nagarajan 
R2  0.746 0.696  0.379# 0.661  0.607 0.677 
s  0.156 0.186  0.244 0.196  0.194 0.192 
MAE  0.47 0.16  0.21 0.67  0.18 0.59 
* R2 and s are the squared correlation coefficient and the standard error of estimate, respectively, of the linear 
regression pKa, experimental = a * pKa, predicted + b, and MAE is the mean absolute error calculated as follows: MAE= 
(1/n) * |pKa, experimental – pKa, predicted|.   
# The particularly low correlation is due to the outlying points belonging to compounds 1y-z, containing carboxyl 
functional group. By excluding them the correlation improves significantly (R2=0.850, n=14) 
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Table 5. Results of regression analyses based on Eq. (5)* 
Dependent variable (pKa1,0 - pKa1,S) (pKa2,0 - pKa2,S) 
No. of data points 22 22 
R2 0.862 0.917 
s 0.090 0.080 
ρ 0.837(0.060) 0.928(0.057) 
No. of data points 20 20 
R2 0.911 0.938 
s 0.075 0.072 
ρ 0.894(0.054) 0.934(0.052) 
   
Hammett equation based on Nagarajan et al.’s work# 
pKa1 = 1.84 - 0.856 ∑σS R2 = 0.975 Eq. (6) 
pKa2 = 7.48 - 0.980 ∑σS R2 = 0.956 Eq. (7) 
Hammett equation based on this work 
pKa1 = 1.70 - 0.894(0.054) ∑σS R2 = 0.911 Eq. (8) 
pKa2 = 6.92 - 0.934(0.052) ∑σS R2 = 0.938 Eq. (9) 
* R2 and s are the squared correlation coefficient and the standard error of estimate, respectively, and the 
values in parentheses are the standard errors of the ρ sensitivity constants  
# The corresponding equations reported in Nagarajan et al.’s work appear to be incorrect, i.e. the sign of the 
intercept in the original publication should be negative. 
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Appendices 
Figure A.1. Correlation between predicted and measured pKa values for the full in-house dataset 
(n=26 compounds, 1a-z) 
  
21 
 
Figure A.2 Correlation between predicted and measured pKa values of the overlapping sets (n=16 
compounds, 1a-n, 1y-z; blue circles: pKa values reported by Nagarajan et al., orange triangles: in-
house measured pKa values) 
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Table A.1. Measured and predicted pKa values of arylphosphonic acid derivatives (1a-x)  1 
1 
Hammet
t σ 
[41] 
 
ACD  
Classic 
 
ACD 
GALAS 
 
Marvin 
Sketch 
 
Nagaraja
n et al. 
 In-house  In-house vs. 
Nagarajan’s 
values  
NMR-pH 
titration 
 pH-metric 
titration 
 cpKa
1 
cpKa
2 
 cpKa
1 
cpKa2 
 
cpKa1 
cpKa
2 
 
pKa1 
pKa
2 
 
pKa1 SD 
 
pKa2 SD 
 |ΔpKa
1| 
|ΔpKa
2| 
a 
0 
 
1.85 7.36 
 
1.90 6.77 
 
1.85 7.24 
 
1.86 
7.5
1 
 
1.70 
0.0
0 
 
6.92 
0.0
0 
 
0.16 0.59 
b 
- 
 
1.75 7.36 
 
1.90 6.77 
 
1.98 7.33 
 
2.08 
7.9
2 
 
1.95 
0.0
0 
 
7.29 
0.0
0 
 
0.13 0.63 
c 
-0.14 
 
1.98 7.62 
 
1.90 6.77 
 
1.97 7.32 
 
2.00 
7.6
8 
 
1.84 
0.0
0 
 
7.08 
0.0
0 
 
0.16 0.60 
d 
0.33 
 
1.52 7.26 
 
1.74 6.61 
 
0.90 6.12 
 
1.53 
7.1
6 
 
1.45 
0.0
0 
 
6.69 
0.0
1 
 
0.08 0.47 
e 
-0.27 
 
2.02 7.66 
 
2.11 6.98 
 
1.66 6.98 
 
2.00 
7.6
8 
 
1.88 
0.0
0 
 
7.28 
0.0
0 
 
0.12 0.40 
f 
- 
 
1.49 7.14 
 
1.70 6.57 
 
1.22 6.54 
 
1.49 
7.1
9 
 
1.35 
0.0
0 
 
6.61 
0.0
0 
 
0.14 0.58 
g 
0.34 
 
1.51 6.97 
 
1.64 6.52 
 
1.22 6.53 
 
1.53 
7.1
6 
 
1.40 
0.0
0 
 
6.60 
0.0
0 
 
0.13 0.56 
h 
0.11 
 
1.75 7.22 
 
1.81 6.68 
 
1.67 6.98 
 
1.74 
7.4
2 
 
1.59 
0.0
1 
 
6.93 
0.0
0 
 
0.15 0.49 
i 
0.23 
 
1.63 7.32 
 
1.73 6.60 
 
1.24 6.54 
 
1.58 
7.2
3 
 
1.47 
0.0
1 
 
6.75* 
0.0
1 
 
0.11 0.48 
j 
0.37 
 
1.50 6.93 
 
1.62 6.49 
 
1.24 6.54 
 
1.53 
7.1
0 
 
1.36 
0.0
2 
 
6.62* 
0.0
1 
 
0.17 0.48 
k 
0.23 
 
1.61 7.30 
 
1.73 6.60 
 
1.26 6.54 
 
1.54 
7.1
8 
 
1.36 
0.0
1 
 
6.61 
0.0
0 
 
0.18 0.57 
l 
0.72 
 
1.20 6.54 
 
1.34 6.21 
 
1.08 6.34 
 
1.20 
6.6
9 
 
0.90 
0.0
2 
 
6.10 
0.0
1 
 
0.30 0.59 
m 
-0.15 
 
1.97 7.63 
 
1.90 6.77 
 
2.03 7.36 
 
1.99 
7.6
5 
 
1.73 
0.0
0 
 
7.02 
0.0
1 
 
0.26 0.63 
23 
 
n 
-0.24 
 
2.03 7.68 
 
2.11 6.98 
 
1.75 7.04 
 
2.00 
7.6
5 
 
1.76 
0.0
1 
 
7.06 
0.0
0 
 
0.24 0.59 
o 
0.50 
 
1.42 6.82 
 
1.52 6.39 
 
1.62 6.91 
 
- - 
 
1.28 
0.0
0 
 
6.48 
0.0
0 
 
- - 
p 
0.53 
 
1.40 6.99 
 
1.50 6.37 
 
0.97 6.21 
 
- - 
 
1.28 
0.0
1 
 
6.48 
0.0
0 
 
- - 
q 
-0.22 
 
1.97 7.59 
 
1.90 6.77 
 
2.12 7.08 
 
- - 
 
1.84 
0.0
0 
 
7.19* 
0.0
1 
 
- - 
r 
0.06 
 
1.72 7.51 
 
1.85 6.73 
 
1.21 6.52 
 
- - 
 
1.59 
0.0
0 
 
6.96 
0.0
0 
 
- - 
s 
- 
 
1.14 6.75 
 
0.93 5.81 
 
0.76 6.02 
 
- - 
 
1.06 
0.0
0 
 
6.32 
0.0
1 
 
- - 
t 
-0.01 
 
1.83 7.47 
 
1.91 6.78 
 
2.13 7.09 
 
- - 
 
1.64 
0.0
1 
 
6.93 
0.0
5 
 
- - 
u 
0.06 
 
1.76 7.29 
 
1.85 6.73 
 
2.13 7.09 
 
- - 
 
1.61 
0.0
1 
 
6.89 
0.0
1 
 
- - 
v 
-0.15 
 
1.98 7.54 
 
1.90 6.77 
 
2.08 7.10 
 
- - 
 
1.80 
0.0
1 
 
7.02 
0.0
1 
 
- - 
w 
0.38 
 
1.50 6.92 
 
1.61 6.49 
 
1.61 6.90 
 
- - 
 
1.36 
0.0
1 
 
6.61 
0.0
0 
 
- - 
x 
-0.20 
 
2.00 7.59 
 
1.90 6.77 
 
2.12 7.11 
 
- - 
 
1.80 
0.0
0 
 
7.05* 
0.0
1 
 
- - 
*determined from cosolvent psKa values measured in MeOH-water mixtures 2 
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Table A.2. Measured and predicted pKa values of arylphosphonic acid derivatives containing carboxyl functional groups (1y-z) 4 
1 
Ham
mett 
σ 
[41] 
ACD Classic ACD GALAS Marvin 
Nagar
ajan et 
al. 
NMR-
pH 
titrati
on 
Differential 
pH-metric 
titration 
In-house 
vs. 
Nagarajan
’s values 
cp
Ka1 
cp
Ka 
COO
H 
cp
Ka2 
cp
Ka1 
cp
Ka 
COO
H 
cp
Ka2 
cp
Ka1 
cp
Ka 
COO
H 
cp
Ka2 
pK
a1 
pK
a2 
pK
a1 
SD 
pK
a 
CO
OH 
SD 
pK
a2 
SD 
|Δp
Ka1| 
|Δp
Ka2| 
y 0.44* 
1.4
9 
3.9
4 
7.2
8 
1.5
5 
4.3
8 
7.1
4 
1.3
9 
3.9
5 
7.0
0 
1.
51 
7.
64 
1.
41 
0.
02 
3.
82 
0.
00 
6.
78 
0.
00 
0.10 0.86 
z 0.35# 
1.5
3 
4.0
0 
7.4
8 
1.6
2 
4.6
7 
7.4
4 
1.3
9 
3.9
6 
6.7
9 
1.
55 
7.
78 
1.
63 
0.
05 
3.
88 
0.
00 
6.
89 
0.
00 
0.08 0.89 
*This Hammett σ value refers to the unionized carboxyl group of compound (1y), while the σ value referring to the ionized carboxylate group is 0.00.  5 
#This Hammett σ value refers to the unionized carboxyl group of compound (1z), while the σ value referring to the ionized carboxylate group is -0.10. 6 
 7 
